The concept is consistent with the finding that a balanced MYC and mitochondrial regulator PGC1A determines pancreatic cancer stem cells.5 Therefore, the coordinated nuclear pluripotency and mitochondrial biogenesis is a distinct feature of CSCs. Here, PPARGC1A is linked to pancreatic neoplasm.